Cargando…

Exploring Nitric Oxide (NO)-Releasing Celecoxib Derivatives as Modulators of Radioresponse in Pheochromocytoma Cells

COX-2 can be considered as a clinically relevant molecular target for adjuvant, in particular radiosensitizing treatments. In this regard, using selective COX-2 inhibitors, e.g., in combination with radiotherapy or endoradiotherapy, represents an interesting treatment option. Based on our own findin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brandt, Florian, Ullrich, Martin, Seifert, Verena, Haase-Kohn, Cathleen, Richter, Susan, Kniess, Torsten, Pietzsch, Jens, Laube, Markus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9573605/ https://www.ncbi.nlm.nih.gov/pubmed/36235124 http://dx.doi.org/10.3390/molecules27196587

Ejemplares similares

Deuteration versus ethylation – strategies to improve the metabolic fate of an (18)F-labeled celecoxib derivative
por: Laube, Markus, et al.
Publicado: (2020)

Development of Antioxidant COX-2 Inhibitors as Radioprotective Agents for Radiation Therapy—A Hypothesis-Driven Review
por: Laube, Markus, et al.
Publicado: (2016)

Radiolabeled COX-2 Inhibitors for Non-Invasive Visualization of COX-2 Expression and Activity — A Critical Update
por: Laube, Markus, et al.
Publicado: (2013)

Synthesis and Cyclooxygenase Inhibition of Sulfonamide-Substituted (Dihydro)Pyrrolo[3,2,1-hi]indoles and Their Potential Prodrugs
por: Laube, Markus, et al.
Publicado: (2019)

CRISPR/Cas9 Mediated Knockout of Cyclooxygenase-2 Gene Inhibits Invasiveness in A2058 Melanoma Cells
por: Haase-Kohn, Cathleen, et al.
Publicado: (2022)

HIF2alpha-Associated Pseudohypoxia Promotes Radioresistance in Pheochromocytoma: Insights from 3D Models
por: Seifert, Verena, et al.
Publicado: (2021)

Targeting Cyclooxygenase-2 in Pheochromocytoma and Paraganglioma: Focus on Genetic Background
por: Ullrich, Martin, et al.
Publicado: (2019)

Impact of Extrinsic and Intrinsic Hypoxia on Catecholamine Biosynthesis in Absence or Presence of Hif2α in Pheochromocytoma Cells
por: Bechmann, Nicole, et al.
Publicado: (2019)

Chronic hypoxia modulates tumour cell radioresponse through cytokine-inducible nitric oxide synthase
por: Berge, D L Van den, et al.
Publicado: (2001)

Interaction of extracellular S100A4 with RAGE prompts prometastatic activation of A375 melanoma cells
por: Herwig, Nadine, et al.
Publicado: (2016)

Characterization of the radioresponse of human apical papilla-derived cells
por: Abe, Shigehiro, et al.
Publicado: (2011)

Characterizing the Radioresponse of Pluripotent and Multipotent Human Stem Cells
por: Lan, Mary L., et al.
Publicado: (2012)

Pathophysiological mechanisms underlying phenotypic differences in pulmonary radioresponse
por: Jackson, Isabel L., et al.
Publicado: (2016)

Strain-specific metastatic phenotypes in pheochromocytoma allograft mice
por: Ullrich, Martin, et al.
Publicado: (2018)

Altered Biological Potential and Radioresponse of Murine Tumors in Different Microenvironments
por: Lee, Ik Jae, et al.
Publicado: (2016)

Corrigendum: Pathophysiological mechanisms underlying phenotypic differences in pulmonary radioresponse
por: Jackson, Isabel L., et al.
Publicado: (2017)

Epigenetic drugs in somatostatin type 2 receptor radionuclide theranostics and radiation transcriptomics in mouse pheochromocytoma models
por: Ullrich, Martin, et al.
Publicado: (2023)

Current Management of Pheochromocytoma/Paraganglioma: A Guide for the Practicing Clinician in the Era of Precision Medicine
por: Nölting, Svenja, et al.
Publicado: (2019)

The Role of Transglutaminase 2 in the Radioresistance of Melanoma Cells
por: Aepler, Julia, et al.
Publicado: (2022)

Three-Dimensional Cell Culture Systems in Radiopharmaceutical Cancer Research
por: Doctor, Alina, et al.
Publicado: (2020)

Cell Cycle Regulating Kinase Cdk4 as a Potential Target for Tumor Cell Treatment and Tumor Imaging
por: Graf, Franziska, et al.
Publicado: (2009)

NF-κB inhibition impairs the radioresponse of hypoxic EMT-6 tumour cells through downregulation of inducible nitric oxide synthase
por: Ridder, M De, et al.
Publicado: (2003)

Establishment of a 3D Model to Characterize the Radioresponse of Patient-Derived Glioblastoma Cells
por: Strand, Zoe, et al.
Publicado: (2023)

Identifying key mutations of radioresponsive genes in esophageal squamous cell carcinoma
por: Xu, Xin, et al.
Publicado: (2022)

Correction: Novel valdecoxib derivatives by ruthenium(ii)-promoted 1,3-dipolar cycloaddition of nitrile oxides with alkynes – synthesis and COX-2 inhibition activity
por: Roscales, Silvia, et al.
Publicado: (2018)

Comparative Saturation Binding Analysis of (64)Cu-Labeled Somatostatin Analogues Using Cell Homogenates and Intact Cells
por: Ullrich, Martin, et al.
Publicado: (2023)

Case report: Incidentally discovered case of pheochromocytoma as a cause of long COVID-19 syndrome
por: Ziegler, Christian G., et al.
Publicado: (2022)

Insights into binding of S100 proteins to scavenger receptors: class B scavenger receptor CD36 binds S100A12 with high affinity
por: Tondera, Christoph, et al.
Publicado: (2016)

Autophagy inhibition radiosensitizes in vitro, yet reduces radioresponses in vivo due to deficient immunogenic signalling
por: Ko, A, et al.
Publicado: (2014)

Identifying Long Non-coding RNA of Prostate Cancer Associated With Radioresponse by Comprehensive Bioinformatics Analysis
por: Xu, Meng, et al.
Publicado: (2020)

Fluctuation in radioresponse of HeLa cells during the cell cycle evaluated based on micronucleus frequency
por: Shimono, Hiroaki, et al.
Publicado: (2020)

Evaluation of Fluorine-18-Labeled α1(I)-N-Telopeptide Analogs as Substrate-Based Radiotracers for PET Imaging of Melanoma-Associated Lysyl Oxidase
por: Kuchar, Manuela, et al.
Publicado: (2018)

Involvement of metformin and AMPK in the radioresponse and prognosis of luminal versus basal-like breast cancer treated with radiotherapy
por: Zhang, Yimin, et al.
Publicado: (2014)

Neoadjuvant olaparib targets hypoxia to improve radioresponse in a homologous recombination-proficient breast cancer model
por: Borst, Gerben R., et al.
Publicado: (2017)

Prospective Evaluation of Local Sustained Release of Celecoxib in Dogs with Low Back Pain
por: Wiersema, Tijn, et al.
Publicado: (2021)

Recombinant human endostatin enhances the radioresponse in esophageal squamous cell carcinoma by normalizing tumor vasculature and reducing hypoxia
por: Zhu, Hongcheng, et al.
Publicado: (2015)

Correction: Neoadjuvant olaparib targets hypoxia to improve radioresponse in a homologous recombination-proficient breast cancer model
por: Borst, Gerben R., et al.
Publicado: (2020)

StemRegenin 1 Mitigates Radiation-Mediated Hematopoietic Injury by Modulating Radioresponse of Hematopoietic Stem/Progenitor Cells
por: Hwang, You Jung, et al.
Publicado: (2023)

Cyclotron-Based Production of (67)Cu for Radionuclide Theranostics via the (70)Zn(p,α)(67)Cu Reaction
por: Brühlmann, Santiago Andrés, et al.
Publicado: (2023)

Cytokinesis-block micronucleus assay of celecoxib and celecoxib derivatives
por: Reimann, Hauke, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_rervrhkqvctcesud4ki0g7nm68